News | April 12, 2026
C4 Therapeutics and Roche launch bold push into next-generation cancer drug modality
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
The initiative is a significant step toward combating antimicrobial resistance (AMR) and reducing environmental contamination from antibiotic waste
The collaboration brings together AIG Hospitals’ high-volume clinical expertise, advanced innovation capabilities, and growing artificial intelligence-led healthcare initiatives
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
The event also featured discussions on emerging trends in joint replacement surgery
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
Subscribe To Our Newsletter & Stay Updated
